2-152575215-A-G
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3
The NM_052905.4(FMNL2):c.676A>G(p.Met226Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000249 in 1,603,938 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Consequence
NM_052905.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152180Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000428 AC: 1AN: 233776 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000207 AC: 3AN: 1451758Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 721200 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152180Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74332 show subpopulations
ClinVar
Submissions by phenotype
FMNL2-related disorder Uncertain:1
The FMNL2 c.676A>G variant is predicted to result in the amino acid substitution p.Met226Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0059% of alleles in individuals of East Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at